EX-99.1 2 dex991.htm PRESS RELEASE DATED MAY 4, 2009 Press release dated May 4, 2009

Exhibit 99.1

LOGO

 

Contacts:       Amy Glynn/Nick Laudico
Devra Shapiro       The Ruth Group
IPC The Hospitalist Company, Inc.     (646) 536-7023/7030
(818) 766-3502       aglynn@theruthgroup.com
      nlaudico@theruthgroup.com

IPC The Hospitalist Company Reports Record First Quarter 2009 Results

North Hollywood, CA—May 4, 2009—IPC The Hospitalist Company, Inc. (NASDAQ: IPCM), a leading national hospitalist physician group practice, today announced financial results for the first quarter ended March 31, 2009.

First Quarter 2009 Highlights (comparisons are to first quarter 2008):

 

   

Net revenue increased 26% to $76.1 million, with same-market area net revenue growth of 19%

 

   

Patient encounters increased 18% to 810,000

 

   

Income from operations rose 39% to $7.6 million

 

   

Operating margin improved 90 basis points to 9.9%

 

   

Net income increased 50% to $4.5 million, or $0.28 per diluted share for the quarter

Adam D. Singer, M.D., Chief Executive Officer of IPC The Hospitalist Company, stated, “Our record results for the first quarter of 2009 reflect IPC’s continued ability to generate strong revenue growth and expand operating margin. The first quarter revenue growth of 26% was driven by increased penetration of same-market areas, as well as the contribution from IPC’s entry into its newest market in Southeast Florida. As we grow our revenue base, we have a significant opportunity to leverage our general and administrative costs, as evidenced by the 90 basis point improvement in our operating margin. We also continued to strengthen our balance sheet by increasing our cash flow and reducing our days sales outstanding, which resulted in an increase in our cash balance.”

Dr. Singer added, “In line with our growth strategy, we are aggressively continuing to recruit new physicians to add to our existing practices. In the first quarter, we also completed two in-market acquisitions in Phoenix, which strengthened our foothold in one of our largest markets. Our acquisition pipeline remains robust in this highly fragmented industry, and we continue to evaluate opportunities across the hospitalist sector. We remain confident that we can continue to grow and penetrate current and new markets through this combination of organic growth and acquisitions. With less than 5% of our encounters coming from elective in-patient stays and uninsured patients remaining stable at approximately 7% of our encounters, we believe we are very well positioned in this challenging economic environment.”

First Quarter 2009

IPC’s first quarter 2009 patient encounters rose 18% to 810,000, compared to 684,000 in the same period last year. Net revenue for the first quarter was $76.1 million, an increase of $15.5 million, or 25.6%, from $60.6 million for the prior year quarter. Of this $15.5 million increase, $11.8 million, or 76.1%, was attributable to same-market area growth and $3.7 million was attributable to revenue generated from a new market acquisition, which was completed in the third quarter of 2008. The change in same-market area net revenue was the result of an 11.9% increase in patient encounters, a 5.9% increase in patient revenue per encounter and an increase in hospital contract revenue. The increase in patient revenue per encounter was partially due to an increase in Medicare reimbursement rates for the billing codes applicable to the services performed by the Company’s hospitalists, as well as improvements in billing processes and collections.

Physician practice salaries, benefits and other expenses for the three months ended March 31, 2009 were $55.5 million, or 72.9%, of net revenue compared to $43.9 million, or 72.6%, of net revenue for the three months ended March 31, 2008. Physician costs as a percentage of net revenue increased slightly as a result of the costs associated with one hospital contract being operated at breakeven, as it is being staffed with locum tenens and other part-time providers at the hospital’s request while IPC recruits employed staff. Excluding this contract, physician costs as a percentage of net revenue for the current quarter were at the same level as the prior year quarter.


General and administrative expenses for the first quarter of 2009 were $12.4 million, compared to $10.7 million for the first quarter of 2008. General and administrative expenses as a percentage of net revenue declined to 16.4% for the first quarter of 2009, compared to 17.7% for the first quarter of 2008, as the Company continues to leverage these costs over a larger revenue base as it grows its existing practices and continues to acquire new practices.

Income from operations for the first quarter of 2009 increased 39.4% to $7.6 million, compared to $5.4 million for the first quarter of 2008. The Company’s operating margin rose to 9.9% for the first quarter of 2009, compared to 9.0% for the first quarter of 2008. The increase in operating margin was primarily the result of the reduction in general and administrative expenses as a percentage of net revenue.

The effective tax rate for the three months ended March 31, 2009 was 40.0%, compared to 42.0% for the three months ended March 31, 2008. The decrease in the effective tax rate reflected a new enterprise zone tax credit recorded for the first time in the fourth quarter of 2008. The Company expects its effective tax rate to remain at 40% for the remainder of 2009.

First quarter 2009 net income increased by 50% to $4.5 million, or $0.28 per diluted share, compared to $3.0 million, or $0.21 per pro-forma diluted share, for the first quarter of 2008.

Cash flow from operations for the first quarter of 2009 was $10.7 million, compared to $2.6 million for the same quarter of 2008. Days sales outstanding (DSO) decreased to 55 DSO at the end of the quarter, compared to 60 DSO as of December 31, 2008, as the Company continued to improve its billing processes and collections. During the quarter, the Company expended $4.8 million for physician practice acquisitions and earn-out payments attributable to practices acquired in 2007 and 2008.

Guidance

For the full year 2009, the Company continues to expect revenue to be in the range of $300 million to $305 million and earnings per diluted share to be in the range of $1.01 to $1.11. The Company has provided this outlook based on the following assumptions: (i) an estimated 4.6% increase in the weighted average reimbursement rates for services provided to Medicare patients; (ii) continued growth in same-market areas whether from new hires or in-market acquisitions; (iii) a 40% effective tax rate; and (iv) 16.3 million weighted average diluted shares outstanding for the year. Not included in the assumptions are (i) new market acquisitions; (ii) increased general and administrative expenses as a result of the requirement of FAS Statement 141(R) to expense external costs associated with acquisitions that close subsequent to December 31, 2008; and (iii) gains or losses related to changes in estimates of earn-outs related to acquisitions that close subsequent to December 31, 2008 as required by FAS Statement 141(R).

Conference Call Information

IPC The Hospitalist Company will host an investor conference call to review the quarterly results at 5:00 p.m. ET (2:00 p.m. PT) today. To participate in the conference call, please dial 877-879-6184 (USA) or 719-325-4789 (International). In addition, a dial-up replay of the conference call will be available beginning May 4, 2009 at 8:00 p.m. ET (5:00 p.m. PT) and ending on May 18, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International) Replay Passcode: 9468818. A live webcast of the call will also be available from the Investor Relations section on the corporate website at http://www.hospitalist.com. A webcast replay can be accessed on the corporate website beginning May 4, 2009 at approximately 8:00 p.m. ET (5:00 p.m. PT) and will remain available until May 18, 2009 at 11:59 p.m.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (NASDAQ: IPCM) is a leading national hospitalist physician group practice focused on the delivery of hospitalist medicine services. IPC’s physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

Safe Harbor Statement

Certain statements and information in this press release may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release may include, but are not limited to, those statements set forth under the section titled “Guidance” regarding projected operating results, revenues, earnings, and IPC’s growth opportunities and strategy. Forward-looking statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions. Any forward-looking statements are necessarily based on a variety of estimates and assumptions which, though considered reasonable by the Company, may not be realized and are inherently subject to significant business, economic, competitive, industry, regulatory, market and financial uncertainties and contingencies, many of which are and will be beyond IPC’s control. Important risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by any forward-looking statements are described in IPC’s most recent Annual Report on Form 10-K, including the section titled “Risk Factors” and actual results could differ materially from those anticipated in forward-looking statements.


In particular the following risks and uncertainties may have such an impact:

 

   

failure to comply with complex and intensive government regulation of our industry;

 

   

the adequacy of our insurance coverage and insurance reserves;

 

   

our ability to recruit and retain qualified physicians;

 

   

our ability to successfully integrate new acquisitions;

 

   

the effect of changes in rates or methods of third-party reimbursement; and

 

   

the high level of competition in our industry.

IPC undertakes no obligation following the date of this press release to update or revise any such statements or projections whether as a result of new information, future events, or otherwise.


IPC The Hospitalist Company, Inc.

Consolidated Balance Sheets

(in thousands, except for share data)

 

     March 31,
2009
(unaudited)
   December 31,
2008

Assets

     

Current assets:

     

Cash and cash equivalents

   $ 42,379    $ 37,394

Accounts receivable, net

     46,035      44,474

Prepaid expenses and other current assets

     5,117      8,081
             

Total current assets

     93,531      89,949

Furniture and equipment, net

     2,412      2,452

Goodwill

     70,752      63,893

Other intangible assets, net

     2,758      2,905

Deferred tax assets, net

     3,492      3,492
             

Total assets

   $ 172,945    $ 162,691
             

Liabilities and Stockholders’ Equity

     

Current liabilities:

     

Accounts payable and accrued liabilities

   $ 5,179    $ 4,664

Accrued compensation

     14,317      11,232

Payables for practice acquisitions

     4,616      2,476

Medical malpractice and self-insurance reserves, current portion

     351      539

Deferred tax liabilities

     481      481

Short-term debt and current portion of capital leases

     3,360      3,471
             

Total current liabilities

     28,304      22,863

Long-term debt and capital leases, less current portion

     4,570      5,368

Medical malpractice and self-insurance reserves, less current portion

     11,580      11,220

Other long-term liabilities

     293      293
             

Total liabilities

     44,747      39,744

Stockholders’ equity:

     

Preferred stock, $0.001 par value, 15,000,000 shares authorized, none issued

     —        —  

Common stock, $0.001 par value, 50,000,000 shares authorized, 16,091,345 and 16,068,835 shares issued and outstanding at March 31, 2009 and December 31, 2008, respectively

     16      16

Additional paid-in capital

     122,759      122,024

Retained earnings

     5,423      907
             

Total stockholders’ equity

     128,198      122,947
             

Total liabilities and stockholders’ equity

   $ 172,945    $ 162,691
             


IPC The Hospitalist Company, Inc.

Consolidated Statements of Income

(dollars in thousands, except for per share data)

(unaudited)

 

     Three Months Ended March 31,  
     2009     2008  

Net revenue

   $ 76,057     $ 60,559  

Operating expenses:

    

Cost of services—physician practice salaries, benefits and other

     55,461       43,943  

General and administrative

     12,441       10,732  

Depreciation and amortization

     588       457  
                

Total operating expenses

     68,490       55,132  
                

Income from operations

     7,567       5,427  

Investment income

     41       164  

Interest expense

     (79 )     (385 )
                

Income before income taxes

     7,529       5,206  

Income tax provision

     3,012       2,186  
                

Net income

     4,517       3,020  

Income allocable to preferred stockholders

     —         (696 )
                

Net income attributable to common stockholders

   $ 4,517     $ 2,324  
                

Per share data:

    

Net income per share attributable to common stockholders—historical:

    

Price per share:

    

Basic

   $ 0.28     $ 0.20  
                

Diluted

   $ 0.28     $ 0.20  
                

Weighted average shares:

    

Basic

     16,089,357       11,434,588  
                

Diluted

     16,258,950       11,831,936  
                

Net income per share attributable to common stockholders—pro forma (1):

    

Basic

     N/A     $ 0.22  
                

Diluted

     N/A     $ 0.21  
                

Weighted average shares

    

Basic

     N/A       13,975,526  
                

Diluted

     N/A       14,212,207  
                

 

(1) Pro forma per share information assumes conversion of our convertible preferred stock and associated warrants at the beginning of 2008 based on the terms of the warrants and convertible preferred stock.


IPC The Hospitalist Company, Inc.

Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)

 

     Three Months Ended
March 31,
 
     2009     2008  

Operating activities

    

Net income

   $ 4,517     $ 3,020  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     588       457  

Stock-based compensation expense

     448       107  

Changes in assets and liabilities:

    

Accounts receivable

     (1,561 )     (3,327 )

Prepaid expenses and other current assets

     2,964       4,744  

Accounts payable

     513       (1,097 )

Accrued compensation

     3,085       (1,984 )

Medical malpractice and self-insurance reserves

     172       729  
                

Net cash provided by operating activities

     10,726       2,649  
                

Investing activities

    

Acquisitions of physician practices

     (4,792 )     (3,452 )

Purchase of furniture and equipment

     (327 )     (495 )
                

Net cash used in investing activities

     (5,119 )     (3,947 )
                

Financing activities

    

Repayments of long-term debt and capital leases, net

     (909 )     (12,382 )

Net proceeds from issuance of common and preferred stock

     270       46,131  

Excess tax benefits from stock-based compensation

     17       74  
                

Net cash (used in) provided by financing activities

     (622 )     33,823  
                

Net increase in cash and cash equivalents

     4,985       32,525  

Cash and cash equivalents, beginning of period

     37,394       6,976  
                

Cash and cash equivalents, end of period

   $ 42,379     $ 39,501  
                


IPC The Hospitalist Company, Inc.

Operating Data

Number of Patient Encounter Data (unaudited):

The following is a summary of the quarterly patient encounters for the five quarters ended March 31, 2009:

 

     Quarter Ended:
     Mar 31,
2008
   Jun 30,
2008
   Sep 30,
2008
   Dec 31,
2008
   Mar 31,
2009

Patient encounters

   684,000    660,000    692,000    754,000    810,000